Rare Voices Podcast

One of the least understood components of commercialization is the role of the payer. For manufacturers, it is hard to know how to set the right strategy. For specialty pharmacies, lack of clarity in payer strategy can create challenges with consistent patient experience. For patients, insurance is a black box that they often feel like they have to navigate alone. Our guest for the second episode of Rare Voices, Jim Clement, a partner at Coeus Consulting, demystifies the assumptions that many of us make about payers. Jim has been there. He has seen the good, the bad, and the ugly of commercialization from every vantage point in the system. Simply put: If you want to be successful in bringing new therapies to patients with rare and orphan disorders, then you need to know Jim.

Show Notes

One of the least understood components of commercialization is the role of the payer. For manufacturers, it is hard to know how to set the right strategy. For specialty pharmacies, lack of clarity in payer strategy can create challenges with consistent patient experience. For patients, insurance is a black box that they often feel like they have to navigate alone. Our guest for the second episode of Rare Voices, Jim Clement, a partner at Coeus Consulting, demystifies the assumptions that many of us make about payers. Jim has been there. He has seen the good, the bad, and the ugly of commercialization from every vantage point in the system. Simply put: If you want to be successful in bringing new therapies to patients with rare and orphan disorders, then you need to know Jim.

What is Rare Voices Podcast?

Rare Voices reveals the wisest path to a fulfilled life for patients with rare and orphan disorders. Brought to you by the people at Optime Care, a pioneering specialty pharmacy. In each episode, we uncover insights from patient advocates, pharmaceutical innovators, leaders in insurance, physicians, and caregivers. Prepare to provoke your mind and fuel your drive to serve rare and orphan patient populations.